The impact of electroconvulsive therapy on the spatial QRS-T angle and cardiac troponin T concentration in psychiatric patients

English version

Autoři: Michał Próchnicki ^aff001; Grzegorz Rudzki ^aff002; Michał Dzikowski ^aff001; Andrzej Jaroszyński ^aff003; Hanna Karakula-Juchnowicz ^aff001
Působiště autorů: I Department of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, Lublin, Poland ^aff001; Department of Endocrinology, Medical University of Lublin, Lublin, Poland ^aff002; Department of Family Medicine and Geriatrics, Jan Kochanowski University, Kielce, Poland ^aff003; Department of Clinical Neuropsychiatry, Medical University of Lublin, Lublin, Poland ^aff004
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pone.0224020

Souhrn

Background

Electroconvulsive therapy (ECT) is an effective treatment method used in psychiatry; however, its cardiac safety has not been clearly demonstrated. The aim of the study was evaluation of the ECT effects on the myocardium based on troponin T concentrations and the following ECG parameters: the spatial QRS-T angle (QRS-TA), QRS duration (QRSd) and the corrected QT interval (QTc).

Methods

In the study 44 patients (12 female and 32 male) were enrolled diagnosed with schizophrenia (n = 21) and major depressive disorders (n = 23), according to the DSM-IVR criteria. All cases were undergoing ECT procedures. The mean age of the patients was 36.9±16 years (range: 18–74). Resting ECG was recorded before performing ECG and 1 hour after. The spatial QRS-TA was reconstructed from 12-lead ECG using the inverse Dower method. Troponin T concentration was assessed before the procedure and 6 hours after ECT.

Results

No significant changes to troponin T concentrations were observed during the ECT series. The pre-ECT value of the spatial QRS-TA was 41.1±18.9°. The follow-up examinations did not reveal any significant increase of this parameter (p = 0.09) in any of the consecutive measurements. There were no significant changes in the QTc interval duration or the QRS complex duration demonstrated before the third, fifth and last procedure in the cycle (p>0.05). No significant changes to troponin T concentrations were observed during the ECT series.

Conclusions

Our findings indicate a lack of negative ECT effects on the risk of adverse cardiovascular events measured by the spatial QRS-T angle and cardiac troponin T concentration.

Klíčová slova:

Analysis of variance – Mental health and psychiatry – Electrocardiography – Depression – Troponin – Hypertension – Arrhythmia – Mental health therapies

Zdroje

1. Wijeratne C, Halliday GS, Lyndon RW. The present status of electroconvulsive therapy: a systematic review. Med J Aust. 1999;171(5):250–4. 10495757.

2. American Psychiatric A. Committee on Electroconvulsive Therapy., Weiner RD. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: a Task Force Report of the American Psychiatric Association. A task force report of the American Psychiatric Association. 2001.

3. Abrams R. The mortality rate with ECT. Convuls Ther. 1997;13(3):125–7. 9342128.

4. Martinez MW, Rasmussen KG, Mueller PS, Jaffe AS. Troponin elevations after electroconvulsive therapy: the need for caution. Am J Med. 2011;124(3):229–34. doi: 10.1016/j.amjmed.2010.09.023 21396506.

5. Hirachan A, Maskey A. Acute myocardial infarction following electroconvulsive therapy in a Schizophrenic patient. Egypt Heart J. 2017;69(1):71–3. Epub 2016/05/25. doi: 10.1016/j.ehj.2016.05.002 29622957; PubMed Central PMCID: PMC5839353.

6. Takagi S, Terasawa Y, Takeuchi T. Asystole a Few Seconds After the Electrical Stimulation of Electroconvulsive Therapy. Psychosomatics. 2018. Epub 2018/03/23. doi: 10.1016/j.psym.2018.03.010 29776678.

7. Sharp RP, Welch EB. Takotsubo cardiomyopathy as a complication of electroconvulsive therapy. Ann Pharmacother. 2011;45(12):1559–65. Epub 2011/11/24. doi: 10.1345/aph.1Q393 22116995.

8. Kalava A, Kalstein A, Koyfman S, Mardakh S, Yarmush JM, Schianodicola J. Pulseless electrical activity during electroconvulsive therapy: a case report. BMC Anesthesiol. 2012;12:8. Epub 2012/05/31. doi: 10.1186/1471-2253-12-8 22650157; PubMed Central PMCID: PMC3403950.

9. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618–e51. doi: 10.1161/CIR.0000000000000617 30571511.

10. Mozos I, Caraba A. Electrocardiographic Predictors of Cardiovascular Mortality. Dis Markers. 2015;2015:727401. Epub 2015/07/16. doi: 10.1155/2015/727401 26257460; PubMed Central PMCID: PMC4519551.

11. Kardys I, Kors JA, van der Meer IM, Hofman A, van der Kuip DA, Witteman JC. Spatial QRS-T angle predicts cardiac death in a general population. Eur Heart J. 2003;24(14):1357–64. doi: 10.1016/s0195-668x(03)00203-3 12871693.

12. Yamazaki T, Froelicher VF, Myers J, Chun S, Wang P. Spatial QRS-T angle predicts cardiac death in a clinical population. Heart Rhythm. 2005;2(1):73–8. doi: 10.1016/j.hrthm.2004.10.040 15851268.

13. Abrams R, Swartz CM. Thymatron® System IV Instruction Manual. Lake Bluff, IL: Somatics LLC; 2006.

14. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesthesia & Analgesia. 2002;94(5):1351–64.

15. Zolezzi M. Medication management during electroconvulsant therapy. Neuropsychiatric disease and treatment. 2016;12:931. doi: 10.2147/NDT.S100908 27143894

16. Jaroszynski A, Czekajska-Chechab E, Drelich-Zbroja A, Zapolski T, Ksiazek A. Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T. Nephrol Dial Transplant. 2009;24(3):1003–8. Epub 2008/10/31. doi: 10.1093/ndt/gfn581 18978067.

17. Bazett HC. An analysis of the time relations of electrocardiograms. Heart. 1920;7:353–70.

18. Johnson JN, Ackerman MJ. QTc: how long is too long? British journal of sports medicine. 2009;43(9):657–62. doi: 10.1136/bjsm.2008.054734 19734499

19. Tecoult E, Nathan N. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol. 2001;18(8):511–8. doi: 10.1046/j.1365-2346.2001.00885.x 11473557.

20. Huuhka MJ, Seinelä L, Reinikainen P, Leinonen EV. Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring. J ECT. 2003;19(1):22–5. 12621273.

21. Kiciński P, Schlegel T, Dybała A, Zakrzewski M, Przybylska-Kuć S, Myśliński W, et al. Spatial QRS-T angle in patients with newly diagnosed obstructive sleep apnea syndrome. Adv Med Sci. 2017;62(2):240–5. Epub 2017/05/11. doi: 10.1016/j.advms.2016.11.008 28501722.

22. Yamaguchi S, Nagao M, Ikeda T, Fukagawa D, Kimura Y, Kitajima T, et al. QT dispersion and rate-corrected QT dispersion during electroconvulsive therapy in elderly patients. J ECT. 2011;27(3):183–8. doi: 10.1097/YCT.0b013e31822145bd 21865956.

23. Masdrakis VG, Tzanoulinos G, Markatou M, Oulis P. Cardiac safety of the electroconvulsive therapy-paliperidone combination: a preliminary study. Gen Hosp Psychiatry. 2011;33(1):83.e9-10. Epub 2010/10/29. doi: 10.1016/j.genhosppsych.2010.09.012 21353140.

24. Dodd ML, Dolenc TJ, Karpyak VM, Rasmussen KG. QTc dispersion in patients referred for electroconvulsive therapy. J ECT. 2008;24(2):131–3. doi: 10.1097/YCT.0b013e3181559834 18580556.

25. Pullen SJ, Rasmussen KG, Angstman ER, Rivera F, Mueller PS. The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram. J ECT. 2011;27(3):192–200. doi: 10.1097/YCT.0b013e31821d3911 21681107.

26. Tezuka N, Egawa H, Fukagawa D, Yamaguchi S, Hamaguchi S, Kitajima T, et al. Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements. J ECT. 2010;26(1):41–6. doi: 10.1097/YCT.0b013e3181a95dbe 20190602.

27. Yilmaz Coşkun F, Elboğa G, Altunbaş G, Vuruşkan E, Uğur BK, Sucu M. Evaluation of ventricular repolarization features with Tp-e, Tp-e/QTc, JTc and JTd during electroconvulsive therapy. J Electrocardiol. 2018;51(3):440–2. Epub 2018/02/12. doi: 10.1016/j.jelectrocard.2018.02.003 29477501.

28. Zabel M, Malik M. Practical use of T wave morphology assessment. Card Electrophysiol Rev. 2002;6(3):316–22. 12114858.

29. Malik M, Acar B, Gang Y, Yap YG, Hnatkova K, Camm AJ. QT dispersion does not represent electrocardiographic interlead heterogeneity of ventricular repolarization. J Cardiovasc Electrophysiol. 2000;11(8):835–43. Epub 2000/09/02. doi: 10.1111/j.1540-8167.2000.tb00061.x 10969744.

30. Rautaharju PM. Why did QT dispersion die? Card Electrophysiol Rev. 2002;6(3):295–301. 12114855.

31. Malik M. QT dispersion: time for an obituary? Eur Heart J. 2000;21(12):955–7. doi: 10.1053/euhj.2000.2070 10901503.

32. Kors JA, Kardys I, van der Meer IM, van Herpen G, Hofman A, van der Kuip DA, et al. Spatial QRS-T angle as a risk indicator of cardiac death in an elderly population. J Electrocardiol. 2003;36 Suppl:113–4. doi: 10.1016/j.jelectrocard.2003.09.033 14716610.

33. Malik M, Hnatkova K, Batchvarov VN. Post infarction risk stratification using the 3-D angle between QRS complex and T-wave vectors. J Electrocardiol. 2004;37 Suppl:201–8. doi: 10.1016/j.jelectrocard.2004.08.058 15534842.

34. Rumi DO, Solimene MC, Takada JY, Grupi CJ, Giorgi DM, Rigonatti SP, et al. Electrocardiographic and blood pressure alterations during electroconvulsive therapy in young adults. Arq Bras Cardiol. 2002;79(2):149–60. Epub 2002/09/10. doi: 10.1590/s0066-782x2002001100007 12219189.